Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Biomaterials consisting of sulphated hyaluronic acid and gellan to be used in the prevention of spinal adhesions

Biomaterials consisting of sulphated hyaluronic acid and gellan to be used in the prevention of spinal adhesions

US Patent 8563039 · Granted Oct 22, 2013

Estimated economic value: $5,156,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Next best action method and system2022
Method and system for guiding agent/customer interactions of a customer relation2021
Data module management and interface for pipeline data processing by a data proc2020
Data transformation of performance statistics and ticket information for network2020
Next best action method and system2019
Method for preparing biocompatible and biodegradable biomaterials based on colla2016
Next best action method and system2016
Biomaterials, their preparation by electrospinning and their use in the biomedic2014
Biomaterials consisting of sulphated hyaluronic acid and gellan to be used in th2014
Biomaterials consisting of sulphated hyaluronic acid and gellan to be used in th2014
Biomaterials consisting of sulphated hyaluronic acid and gellan to be used in th2014
Biomaterials consisting of sulphated hyaluronic acid and gellan to be used in th2014